Search
Foghorn Therapeutics Inc.
FHTXAdd to Watchlist
3.600USD
-0.270-6.98%
Close 09-23 16:00（ET）
211.36MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-6.98%
5 Days
-13.67%
1 Month
-49.08%
6 Months
-29.27%
Year to Date
-33.33%
1 Year
-28.14%
Key Figures
3.830Open
4.210High
29.20KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.05%Turnover Ratio
3.870Prev. Close
3.560Low
105.66KTurnover
LossP/E Static
-2.61P/B
0.00%Div Yield TTM
-31.33%ROA
7.61052wk High
0.05Volume Ratio
-86.62MNet Profit
58.71MShares
-1.1656EPS TTM
2.91Beta
-470.38%ROE
3.27052wk Low
16.80%Amplitude
100.00%Gross Margin
211.36MMarket Cap
4.69Reward/Risk
4.79%Risk Rate
More news coming soon, stay tuned...
Foghorn Therapeutics Inc.'s Score
0.05vs previous score
Forecast9.00
Financial Health8.65
Technical5.69
Valuation Dimensions8.04
Institutional Confidence7.00
Risk Assessment3.58
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Foghorn Therapeutics Inc. Technical Analysis
Technical Indicators
Strong sell
Summary
Strong sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.10/-0.26
Revenue / Forecast
16.07M/6.00M
Foghorn Therapeutics Inc. Profile
SectorBiotechnology & Medical Research
Ticker SymbolFHTX
Number of employees112
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Flagship Ventures | 21.59% |
| Fidelity Management & Research Company LLC | 9.19% |
| BVF Partners L.P. | 9.03% |
| Eli Lilly and Company | 6.81% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 22.50% |
| Venture Capital | 21.61% |
| Hedge Fund | 17.42% |
| Corporation | 10.46% |
Related Instruments
+2.86%
+0.56%
+0.02%
-0.07%
+0.60%
+0.75%
-0.01%
-1.11%
+1.18%
+0.82%
+1.17%
+0.57%
-1.27%
-0.12%
-1.73%
-0.72%
+6.98%
+1.73%
-1.17%
+0.61%Popular Instruments
51297.000
-193.000 (-0.38%)
30442.500
-35.400 (-0.12%)
7694.800
-12.200 (-0.16%)
14260.000
-162.000 (-1.12%)
65649.000
-480.000 (-0.73%)
6300.200
+10.200 (+0.16%)
94.433
+1.943 (+2.10%)
335.920
-1.100 (-0.33%)
224.580
-0.930 (-0.41%)
4274.760
-11.480 (-0.27%)
FAQs
What is the current price of Foghorn Therapeutics Inc. (FHTX)?
The current price of Foghorn Therapeutics Inc. (FHTX) is 3.87.
What is the symbol of Foghorn Therapeutics Inc.?
The ticker symbol of Foghorn Therapeutics Inc. is FHTX.
What is the 52-week high of Foghorn Therapeutics Inc.?
The 52-week high of Foghorn Therapeutics Inc. is 7.61.
What is the 52-week low of Foghorn Therapeutics Inc.?
The 52-week low of Foghorn Therapeutics Inc. is 3.27.
What is the market capitalization of Foghorn Therapeutics Inc.?
The market capitalization of Foghorn Therapeutics Inc. is 227.21M.
Is Foghorn Therapeutics Inc. (FHTX) currently rated as Buy, Hold, or Sell?
According to analysts, Foghorn Therapeutics Inc. (FHTX) has an overall rating of STRONG BUY, with a price target of 11.44.
What is the Earnings Per Share (EPS TTM) of Foghorn Therapeutics Inc. (FHTX)?
The Earnings Per Share (EPS TTM) of Foghorn Therapeutics Inc. (FHTX) is -1.17.